Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Dec;70(830):905–909. doi: 10.1136/pgmj.70.830.905

Arterial thrombosis in the nephrotic syndrome.

I H Fahal 1, P McClelland 1, C R Hay 1, G M Bell 1
PMCID: PMC2398016  PMID: 7870639

Abstract

Thrombosis is a frequent cause of morbidity and mortality in patients with the nephrotic syndrome. Venous thrombotic complications are well recognized but arterial complications are rare. Thrombosis is multifactorial, and has been attributed to a hypercoaguable state due to alterations in blood levels of the various factors involved in the coagulation and fibrinolytic systems, alterations in platelet function, venous stasis, haemoconcentration, increased blood viscosity and possibly the administration of steroids. Thrombosis in general and arterial thrombosis in particular is a significant and potentially serious problem in nephrotic patients. Awareness of the condition and its pathogenesis is needed. Assessment for the risk factors is required to allow appropriate prophylactic measures to be taken.

Full text

PDF
905

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler A. J., Lundin A. P., Feinroth M. V., Friedman E. A., Berlyne G. M. Beta-thromboglobulin levels in the nephrotic syndrome. Am J Med. 1980 Oct;69(4):551–554. doi: 10.1016/0002-9343(80)90466-0. [DOI] [PubMed] [Google Scholar]
  2. Andrassy K., Ritz E., Bommer J. Hypercoagulability in the Nephrotic syndrome. Klin Wochenschr. 1980 Oct 1;58(19):1029–1036. doi: 10.1007/BF01476873. [DOI] [PubMed] [Google Scholar]
  3. Bellomo R., Atkins R. C. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron. 1993;63(3):249–254. doi: 10.1159/000187205. [DOI] [PubMed] [Google Scholar]
  4. Bergstein J. M. Prostaglandin inhibitors in the treatment of nephrotic syndrome. Pediatr Nephrol. 1991 May;5(3):335–338. doi: 10.1007/BF00867497. [DOI] [PubMed] [Google Scholar]
  5. Boneu B. Facteurs prédisposant aux thromboses. Nouv Rev Fr Hematol. 1993 Jun;35(3):187–190. [PubMed] [Google Scholar]
  6. Cameron J. S. Coagulation and thromboembolic complications in the nephrotic syndrome. Adv Nephrol Necker Hosp. 1984;13:75–114. [PubMed] [Google Scholar]
  7. Carvalho A. C., Colman R. W., Lees R. S. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974 Feb 21;290(8):434–438. doi: 10.1056/NEJM197402212900805. [DOI] [PubMed] [Google Scholar]
  8. Cosio F. G., Harker C., Batard M. A., Brandt J. T., Griffin J. H. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med. 1985 Aug;106(2):218–222. [PubMed] [Google Scholar]
  9. Garbrecht F., Gardner S., Johnson V., Grabowski E. Deep venous thrombosis in a child with nephrotic syndrome associated with a circulating anticoagulant and acquired protein S deficiency. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):330–333. doi: 10.1097/00043426-199123000-00015. [DOI] [PubMed] [Google Scholar]
  10. Gouault-Heilmann M., Gadelha-Parente T., Levent M., Intrator L., Rostoker G., Lagrue G. Total and free protein S in nephrotic syndrome. Thromb Res. 1988 Jan 1;49(1):37–42. doi: 10.1016/0049-3848(88)90357-x. [DOI] [PubMed] [Google Scholar]
  11. Green D., Arruda J., Honig G., Muehrcke R. C. Urinary loss of clotting factors due to hereditary membranous glomerulopathy. Am J Clin Pathol. 1976 Mar;65(3):376–383. doi: 10.1093/ajcp/65.3.376. [DOI] [PubMed] [Google Scholar]
  12. Handley D. A., Lawrence J. R. Factor-IX deficiency in the nephrotic syndrome. Lancet. 1967 May 20;1(7499):1079–1081. doi: 10.1016/s0140-6736(67)92651-7. [DOI] [PubMed] [Google Scholar]
  13. Heeg J. E., de Jong P. E., van der Hem G. K., de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989 Aug;36(2):272–279. doi: 10.1038/ki.1989.190. [DOI] [PubMed] [Google Scholar]
  14. Kanfer A., Kleinknecht D., Broyer M., Josso F. Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thromb Diath Haemorrh. 1970 Dec 31;24(3):562–571. [PubMed] [Google Scholar]
  15. Kauffmann R. H., Veltkamp J. J., Van Tilburg N. H., Van Es L. A. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med. 1978 Oct;65(4):607–613. doi: 10.1016/0002-9343(78)90848-3. [DOI] [PubMed] [Google Scholar]
  16. Kendall A. G., Lohmann R. C., Dossetor J. B. Nephrotic syndrome. A hypercoagulable state. Arch Intern Med. 1971 Jun;127(6):1021–1027. [PubMed] [Google Scholar]
  17. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985 Sep;28(3):429–439. doi: 10.1038/ki.1985.149. [DOI] [PubMed] [Google Scholar]
  18. Llach F. Thromboembolic complications in nephrotic syndrome. Coagulation abnormalities, renal vein thrombosis, and other conditions. Postgrad Med. 1984 Nov 1;76(6):111-4, 116-8, 121-3. doi: 10.1080/00325481.1984.11698782. [DOI] [PubMed] [Google Scholar]
  19. Natelson E. A., Lynch E. C., Hettig R. A., Alfrey C. P., Jr Acquired factor IX deficiency in the nephrotic syndrome. Ann Intern Med. 1970 Sep;73(3):373–378. doi: 10.7326/0003-4819-73-3-373. [DOI] [PubMed] [Google Scholar]
  20. OZSOYLU S., STRAUSS H. S., DIAMOND L. K. Effects of corticosteroids on coagulation of the blood. Nature. 1962 Sep 22;195:1214–1215. doi: 10.1038/1951214a0. [DOI] [PubMed] [Google Scholar]
  21. Ozanne P., Francis R. B., Meiselman H. J. Red blood cell aggregation in nephrotic syndrome. Kidney Int. 1983 Mar;23(3):519–525. doi: 10.1038/ki.1983.50. [DOI] [PubMed] [Google Scholar]
  22. Patel R., Mandal A. K. Arterial thrombosis associated with the nephrotic syndrome. J Cardiovasc Surg (Torino) 1978 Mar-Apr;19(2):129–134. [PubMed] [Google Scholar]
  23. Remuzzi G., Mecca G., Marchesi D., Livio M., de Gaetano G., Donati M. B., Silver M. J. Platelet hyperaggregability and the nephrotic syndrome. Thromb Res. 1979;16(3-4):345–354. doi: 10.1016/0049-3848(79)90082-3. [DOI] [PubMed] [Google Scholar]
  24. Robert A., Olmer M., Sampol J., Gugliotta J. E., Casanova P. Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int. 1987 Mar;31(3):830–835. doi: 10.1038/ki.1987.73. [DOI] [PubMed] [Google Scholar]
  25. Schafer A. I., Kroll M. H. Nonatheromatous arterial thrombosis. Annu Rev Med. 1993;44:155–170. doi: 10.1146/annurev.me.44.020193.001103. [DOI] [PubMed] [Google Scholar]
  26. Schumacher W. A., Heran C. H., Steinbacher T. E., Megill J. R., Bird J. E., Giancarli M. R., Durham S. K. Thrombin inhibition compared with other antithrombotic drugs in rats. Thromb Res. 1992 Oct 15;68(2):157–166. doi: 10.1016/0049-3848(92)90031-5. [DOI] [PubMed] [Google Scholar]
  27. Simpson H. C., Mann J. I., Meade T. W., Chakrabarti R., Stirling Y., Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983 Apr 9;1(8328):786–790. doi: 10.1016/s0140-6736(83)91849-4. [DOI] [PubMed] [Google Scholar]
  28. Takeda Y., Chen A. Y. Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. J Lab Clin Med. 1967 Oct;70(4):678–685. [PubMed] [Google Scholar]
  29. Thaler E., Balzar E., Kopsa H., Pinggera W. F. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis. 1978;7(5):257–272. doi: 10.1159/000214268. [DOI] [PubMed] [Google Scholar]
  30. Ueda N., Kawaguchi S., Niinomi Y., Nonoda T., Matsumoto J., Ohnishi M., Yasaki T. Effect of corticosteroids on coagulation factors in children with nephrotic syndrome. Pediatr Nephrol. 1987 Jul;1(3):286–289. doi: 10.1007/BF00849225. [DOI] [PubMed] [Google Scholar]
  31. Vaziri N. D., Alikhani S., Patel B., Nguyen Q., Barton C. H., Gonzales E. V. Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron. 1988;49(1):20–23. doi: 10.1159/000184980. [DOI] [PubMed] [Google Scholar]
  32. Vaziri N. D., Ngo J. L., Ibsen K. H., Mahalwas K., Roy S., Hung E. K. Deficiency and urinary losses of factor XII in adult nephrotic syndrome. Nephron. 1982;32(4):342–346. doi: 10.1159/000182876. [DOI] [PubMed] [Google Scholar]
  33. Vaziri N. D., Ngo J. L., Ibsen K. H., Mahalwas K., Roy S., Hung E. K. Deficiency and urinary losses of factor XII in adult nephrotic syndrome. Nephron. 1982;32(4):342–346. doi: 10.1159/000182876. [DOI] [PubMed] [Google Scholar]
  34. Vaziri N. D., Paule P., Toohey J., Hung E., Alikhani S., Darwish R., Pahl M. V. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med. 1984 Sep;144(9):1802–1803. [PubMed] [Google Scholar]
  35. Vesvres M. H., Doutremepuich F., Lalanne M. C., Doutremepuich C. Effects of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemostasis. 1993;23(1):8–12. doi: 10.1159/000216846. [DOI] [PubMed] [Google Scholar]
  36. Vigano-D'Angelo S., D'Angelo A., Kaufman C. E., Jr, Sholer C., Esmon C. T., Comp P. C. Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med. 1987 Jul;107(1):42–47. doi: 10.7326/0003-4819-107-1-42. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES